Adipocyte specific delivery of oral thiazolidinedione nanoparticles functionalized with RGD and P3 peptides to reduce side effects and improve efficacy

dc.contributor.guide	Praveen, T K
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Garikapati Kusuma, Kumari
dc.date.accessioned	2023-12-28T09:00:53Z
dc.date.available	2023-12-28T09:00:53Z
dc.date.awarded	2023
dc.date.completed	2023
dc.date.registered	2019
dc.description.abstract	Available
dc.description.note	Summary 128-132p Reference 133-140p
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-146p
dc.identifier.uri	http://hdl.handle.net/10603/534171
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	141
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Diabetes mellitus, Adipocyte site specific drug delivery, Thiazolidinediones, Pioglitazone nanoparticles, off-target and target side effects
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Adipocyte specific delivery of oral thiazolidinedione nanoparticles functionalized with RGD and P3 peptides to reduce side effects and improve efficacy
dc.title.alternative
dc.type.degree	Ph.D.